<bill session="116" type="h" number="4640" updated="2022-11-01T13:49:42Z">
  <state datetime="2019-10-11">REFERRED</state>
  <status>
    <introduced datetime="2019-10-11"/>
  </status>
  <introduced datetime="2019-10-11"/>
  <titles>
    <title type="display">Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2019</title>
    <title type="official" as="introduced">To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.</title>
    <title type="short" as="introduced">Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2019</title>
  </titles>
  <sponsor bioguide_id="D000191"/>
  <cosponsors>
    <cosponsor bioguide_id="C001068" joined="2019-11-18"/>
    <cosponsor bioguide_id="D000216" joined="2019-10-31"/>
    <cosponsor bioguide_id="D000399" joined="2019-10-18"/>
    <cosponsor bioguide_id="G000586" joined="2019-12-23"/>
    <cosponsor bioguide_id="G000551" joined="2019-11-08"/>
    <cosponsor bioguide_id="K000009" joined="2019-12-03"/>
    <cosponsor bioguide_id="K000389" joined="2019-10-21"/>
    <cosponsor bioguide_id="P000597" joined="2019-12-18"/>
    <cosponsor bioguide_id="P000607" joined="2019-10-28"/>
    <cosponsor bioguide_id="S001145" joined="2019-10-30"/>
    <cosponsor bioguide_id="W000800" joined="2019-10-22"/>
  </cosponsors>
  <actions>
    <action datetime="2019-10-11">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-10-11" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-10-14">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Health programs administration and funding"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Inflation and prices"/>
    <term name="Intellectual property"/>
    <term name="Medical research"/>
    <term name="Research and development"/>
  </subjects>
  <amendments/>
  <summary date="2021-09-01T20:21:22Z" status="Introduced in House">Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2019

This bill prohibits federal agencies and nonprofit entities that conduct federally funded health care research from providing a patent for a drug based on such research until the entity receiving the patent enters into a reasonable pricing agreement with the Department of Health and Human Services.</summary>
</bill>
